Center for Immunization Research East, Johns Hopkins Bayview Medical Center Campus

Baltimore, Maryland 21224

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus Infections

Studies at this site

• Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age — Stopped early